NPHS1 and focal segmental glomerulosclerosis: [12] further corroborated these findings by showing that serum levels of anti-nephrin autoantibodies were considerably elevated in patients with recurrent focal segmental glomerulosclerosis (FSGS) post-kidney transplantation and subsequently decreased as the disease went into remission.